You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 154 No. 10, October 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (24)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Asthma
 •Immunology
 •Allergy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Higher-Dose Intravenous Magnesium Therapy for Children With Moderate to Severe Acute Asthma

Lydia Ciarallo, MD; David Brousseau, MD; Steven Reinert, MS

Arch Pediatr Adolesc Med. 2000;154:979-983.

Objective  To evaluate the efficacy of a 40-mg/kg dose of intravenous magnesium sulfate for moderate to severe asthma exacerbations in pediatric patients.

Study design  Double-blind placebo-controlled trial.

Setting  Two urban tertiary care pediatric emergency departments.

Subjects  Thirty patients, aged 6 to 17.9 years, being treated for an acute asthma exacerbation.

Intervention  Eligible patients received either a magnesium sulfate infusion of 40 mg/kg or saline solution.

Results  At 20 minutes, the time at which the infusion was completed, the magnesium group had a significantly greater percentage of absolute improvement from baseline in each of the following: predicted peak expiratory flow rate (8.6% vs 0.3%, P<.001), forced expiratory volume in 1 second (7.0% vs 0.2%,P<.001), and forced vital capacity (7.3% vs –0.7%, P<.001). The improvement was greater at 110 minutes: peak expiratory flow rate (25.8% vs 1.9%, P<.001), forced expiratory volume in 1 second (24.1% vs 2.3%; P<.001), and forced vital capacity (27.3% vs 2.6%, P<.001). Patients who received intravenous magnesium were more likely to be discharged to their homes than those who received the placebo (8/16 vs 0/14; P= .002).

Conclusion  Children treated with 40 mg/kg of intravenous magnesium sulfate for moderate to severe asthma showed remarkable improvement in short-term pulmonary function.


From the Department of Pediatrics, Brown University School of Medicine and Department of Emergency Medicine, Rhode Island Hospital (Drs Ciarallo and Brousseau), and the Lifespan Medical Computing Department, Rhode Island Hospital (Mr Reinert), Providence.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Remembering the Patient
Peter J. Gergen
Arch Pediatr Adolesc Med. 2000;154(10):977-978.
EXTRACT | FULL TEXT  

Nebulizer Use in Inner-City Children With Asthma: Morbidity, Medication Use, and Asthma Management Practices
Arlene M. Butz, Peyton Eggleston, Karen Huss, Ken Kolodner, and Cynthia Rand
Arch Pediatr Adolesc Med. 2000;154(10):984-990.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Magnesium for treatment of asthma in children
Bichara and Goldman
cfp 2009;55:887-889.
ABSTRACT | FULL TEXT  

Intravenous and nebulised magnesium sulphate for acute asthma: systematic review and meta-analysis
Mohammed and Goodacre
Emerg. Med. J. 2007;24:823-830.
ABSTRACT | FULL TEXT  

Highlights in asthma 2005.
Heraghty and Henderson
Arch. Dis. Child. 2006;91:422-425.
ABSTRACT | FULL TEXT  

A meta-analysis on intravenous magnesium sulphate for treating acute asthma
Cheuk et al.
Arch. Dis. Child. 2005;90:74-77.
ABSTRACT | FULL TEXT  

The pulmonary physician in critical care * 12: Acute severe asthma in the intensive care unit
Phipps and Garrard
Thorax 2003;58:81-88.
ABSTRACT | FULL TEXT  

Asthma Management, Part II: Pharmacologic Management
Baker et al.
The Journal of School Nursing 2002;18:257-269.
ABSTRACT | FULL TEXT  

IV Magnesium Sulfate in the Treatment of Acute Severe Asthma* : A Multicenter Randomized Controlled Trial
Silverman et al.
Chest 2002;122:489-497.
ABSTRACT | FULL TEXT  

Does magnesium sulphate have a role in the management of paediatric status asthmaticus?
Markovitz
Arch. Dis. Child. 2002;86:381-382.
FULL TEXT  

The Management of Acute Severe Asthma
Kelly
Journal of Pharmacy Practice 2001;14:91-107.
ABSTRACT  

Higher-Dose Magnesium Is Helpful for Children with Moderate-to-Severe Asthma
JWatch Emergency Med. 2001;2001:1-1.
FULL TEXT  

Magnesium Therapy May Improve Pulmonary Function in Severe Acute Asthma
Bratton
AAP Grand Rounds 2001;5:4-5.
FULL TEXT  

Magnesium Therapy in Children with Acute Asthma
JWatch General 2000;2000:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.